about
Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertralineA pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertralineNon-REM sleep instability in patients with major depressive disorder: subjective improvement and improvement of non-REM sleep instability with treatment (Agomelatine).Sodium oxybate and sleep apnea: a clinical caseThe melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice.Impact of the novel antidepressant agomelatine on disturbed sleep-wake cycles in depressed patients.Safety profile of tasimelteon, a melatonin MT1 and MT2 receptor agonist: pooled safety analyses from six clinical studies.
P50
Q28274642-0E95864C-90F1-4C6E-935B-01B91B96C1C0Q28286878-9951C8DC-C838-425C-937C-8F32E9B77FD5Q34582696-418EB1AF-1F88-4FAC-8B5B-68C18CC93970Q35583105-082424FE-4180-48D8-B19B-5F853714834EQ37007350-B72A2A8B-DC39-40E5-AB37-C6707B615BB1Q37725848-1C68367C-26DA-45C1-B89C-0A93D962FE4BQ40515321-CA2FB407-1EA7-4BF1-8EBA-48883D97FDC5
P50
name
Maria-Antonia Quera-Salva
@ast
Maria-Antonia Quera-Salva
@en
Maria-Antonia Quera-Salva
@es
Maria-Antonia Quera-Salva
@nl
type
label
Maria-Antonia Quera-Salva
@ast
Maria-Antonia Quera-Salva
@en
Maria-Antonia Quera-Salva
@es
Maria-Antonia Quera-Salva
@nl
prefLabel
Maria-Antonia Quera-Salva
@ast
Maria-Antonia Quera-Salva
@en
Maria-Antonia Quera-Salva
@es
Maria-Antonia Quera-Salva
@nl